Medication info
Cefar Tablet 250 mg (Cefuroxime Axetil)

Cefar Tablet 250 mg (Cefuroxime Axetil)

Prescription medicationTabletOral
Ingredient · strength
Cefuroxime Axetil›300.72mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White, oval, film-coated tablet
Packaging
50 tablets (10 tablets/PTP × 5)
Approval status
Active

MFDS item code 201803488 · Approved 2018.08.28 · Insurance code 657806270

Summary

Main use
Treatment of respiratory and genitourinary infections (including gonorrhea), skin and soft tissue infections, and early Lyme disease
Who takes it
Adults · Children
Adult dose
For optimal absorption, this medicine should be taken after meals. Most infections: Administer 250mg twice daily. Severe lower respiratory tract infections, pneumonia, severe infections, or suspected infections caused by less susceptible organisms: Administer 500mg twice daily. Urinary tract infections: Administer 250mg twice daily. Uncomplicated gonorrhea: Administer a single dose of 1g. Lyme disease: Administer 500mg twice daily for 14 days (10~21 days). For the treatment of infections caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci), this medicine should be administered for 7~10 days. Patients with renal impairment: Creatinine clearance ≥ 30 mL/min/1.73m2, T1/2 (hours) 1.4 - 2.4: No dosage adjustment is necessary (standard dose: 125mg-500mg twice daily) Patients with renal impairment: Creatinine clearance 10 - 29 mL/min/1.73m2, T1/2 (hours) 4.6: Administer the standard single dose every 24 hours Patients with renal impairment: Creatinine clearance < 10 mL/min/1.73m2, T1/2 (hours) 16.8: Administer the standard single dose every 48 hours Patients undergoing hemodialysis: T1/2 (hours) 2 - 4: Administer an additional standard single dose at the end of each dialysis session
Child dose
Children 12 years and older: Most infections: Administer 250mg twice daily. Children 12 years and older: Severe lower respiratory tract infections, pneumonia, severe infections, or suspected infections caused by less susceptible organisms: Administer 500mg twice daily. Children 12 years and older: Urinary tract infections: Administer 250mg twice daily. Children 12 years and older: Uncomplicated gonorrhea: Administer a single dose of 1g. Children 12 years and older: Lyme disease: Administer 500mg twice daily for 14 days (10~21 days). Infants and children under 12 years: Most infections: Administer 125mg twice daily. Otitis media in children 2 years and older, severe infections: Administer 250mg twice daily. Infants and children under 12 years: Lyme disease: Administer 250mg twice daily for 14 days (10~21 days). Infants under 3 months: There is insufficient experience with use.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and genitourinary infections (including gonorrhea), skin and soft tissue infections, and early Lyme disease

  • Otitis media
  • sinusitis
  • tonsillitis
  • pharyngitis
  • acute and chronic bronchitis
  • pneumonia
  • pyelonephritis
  • cystitis
  • urethritis
  • boils
  • impetigo
  • pyoderma
View approved original text

Cefuroxime is an antibiotic that has strong efficacy against various bacteria, especially stable against beta-lactamase, and effective against strains resistant to ampicillin and amoxicillin. This medication is used to treat upper respiratory infections such as otitis media, sinusitis, tonsillitis, and pharyngitis. Additionally, it shows good therapeutic effect for lower respiratory tract infections such as acute and chronic bronchitis and pneumonia. It can also be used for genitourinary infections such as pyelonephritis, cystitis, and urethritis, and it is used to treat skin and soft tissue infections like boils, impetigo, and pyoderma. This drug is also useful for the treatment of gonorrhea, including acute urethritis and cervicitis caused by Neisseria gonorrhoeae, and for the treatment of early Lyme disease. Thus, cefuroxime effectively improves various infections.

How to take

Adult dose

For optimal absorption, this medicine should be taken after meals. Most infections: Administer 250mg twice daily. Severe lower respiratory tract infections, pneumonia, severe infections, or suspected infections caused by less susceptible organisms: Administer 500mg twice daily. Urinary tract infections: Administer 250mg twice daily. Uncomplicated gonorrhea: Administer a single dose of 1g. Lyme disease: Administer 500mg twice daily for 14 days (10~21 days). For the treatment of infections caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci), this medicine should be administered for 7~10 days. Patients with renal impairment: Creatinine clearance ≥ 30 mL/min/1.73m2, T1/2 (hours) 1.4 - 2.4: No dosage adjustment is necessary (standard dose: 125mg-500mg twice daily) Patients with renal impairment: Creatinine clearance 10 - 29 mL/min/1.73m2, T1/2 (hours) 4.6: Administer the standard single dose every 24 hours Patients with renal impairment: Creatinine clearance < 10 mL/min/1.73m2, T1/2 (hours) 16.8: Administer the standard single dose every 48 hours Patients undergoing hemodialysis: T1/2 (hours) 2 - 4: Administer an additional standard single dose at the end of each dialysis session

Child dose

Children 12 years and older: Most infections: Administer 250mg twice daily. Children 12 years and older: Severe lower respiratory tract infections, pneumonia, severe infections, or suspected infections caused by less susceptible organisms: Administer 500mg twice daily. Children 12 years and older: Urinary tract infections: Administer 250mg twice daily. Children 12 years and older: Uncomplicated gonorrhea: Administer a single dose of 1g. Children 12 years and older: Lyme disease: Administer 500mg twice daily for 14 days (10~21 days). Infants and children under 12 years: Most infections: Administer 125mg twice daily. Otitis media in children 2 years and older, severe infections: Administer 250mg twice daily. Infants and children under 12 years: Lyme disease: Administer 250mg twice daily for 14 days (10~21 days). Infants under 3 months: There is insufficient experience with use.

Precautions

This drug should not be administered to patients with hypersensitivity to cephalosporin-type antibiotics. Caution is advised in patients with a history of allergy to penicillin or other beta-lactam antibiotics, and in patients who frequently experience allergic symptoms such as bronchial asthma, rashes, or hives. Close monitoring is required for elderly patients with severely reduced kidney function, those unable to take oral medication or in poor nutritional status, and those with poor general health. During the administration of this drug, if unusual symptoms such as rashes, hives, itching, difficulty breathing, severe diarrhea, abdominal pain, or dizziness occur, it is important to notify the medical staff immediately and discontinue the medication. Prolonged use may lead to excessive proliferation of non-susceptible organisms such as Candida or Clostridium difficile, so therapy should be discontinued if such symptoms occur. Since this medication may affect kidney function, regular blood tests and kidney function tests are necessary; if abnormalities are found, treatment should be discontinued and appropriate measures taken. This drug can cause dizziness, so caution should be exercised when driving or operating machinery. Women who are pregnant or may become pregnant should use this drug only when the benefits outweigh the risks, and caution is required during breastfeeding as well. Safety has not been established for infants under 3 months of age, and when administering to children, it is preferable to use a dry syrup formulation to avoid the bitter taste. In elderly patients, adverse reactions may occur more easily due to decreased physiological function, thus careful observation and adjustment of dosage and administration interval are necessary. This drug may interact with other medications; caution is advised when taken concurrently with diuretics, aminoglycoside antibiotics, probenecid, antacids, etc. In case of overdose, seizures may occur, so immediate medical assistance should be sought, and drug concentration can be lowered by hemodialysis or peritoneal dialysis. Lastly, store the medication out of reach of children, and keep it sealed in its original container to maintain the quality of the drug.

Side effects

  • Candida overgrowth
  • eosinophilia
  • positive Coombs test
  • thrombocytopenia
  • leukopenia
  • granulocytopenia
  • anemia
  • hemoglobin decrease
  • hematocrit decrease
  • hemolytic anemia
Show 50 more
  • skin rash
  • urticaria
  • itching
  • drug fever
  • serum sickness
  • anaphylaxis
  • facial swelling
  • lymphadenopathy
  • arthralgia
  • headache
  • dizziness
  • diarrhea
  • nausea
  • abdominal pain
  • vomiting
  • dyspepsia
  • constipation
  • loss of appetite
  • membranous colitis
  • abdominal distention
  • fever
  • cough
  • respiratory distress
  • abnormal chest X-ray
  • interstitial pneumonia
  • eosinophilic pulmonary infiltrates
  • temporary increase in liver enzymes
  • jaundice
  • hepatitis
  • increased BUN
  • acute renal failure
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B deficiency
  • otalgia
  • perioral sensory disturbances
  • tongue numbness
  • pharyngeal abnormalities
  • dry mouth
  • palpitations
  • eczema
  • Churg-Strauss syndrome
  • DRESS syndrome
  • discomfort
  • oral abnormalities
  • wheezing
  • tinnitus
  • sweating

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent exposure to air and moisture. Also, it is advisable to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White, oval, film-coated tablet

Package unit

50 tablets (10 tablets/PTP × 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.